RL

Rama Lakshmi Gorti

Director Designated Partner DIN 08276477
DIN 08276477 First appointment Nov 2018 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2018
Shareholding value •••• Premium profile

About Rama Lakshmi Gorti

Data last updated:

Rama Lakshmi Gorti was a Designated Partner at Immunus Biotech Llp (2020–2024) and Director at Medivast Pharmatech Private Limited (2018–2021). The companies operate in Business Services and Pharma.

DIN 08276477
Primary Designation Designated Partner
Industry Business Services
First Appointment 27 Nov 2018

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner23 Oct 20202020Active
Medivast Pharmatech Private Limited U51909TG2018PTC128562
Director27 Nov 20182018₹20,420 (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Immunus Biotech Llp
Medivast Pharmatech Private Limited
Premium access

Shareholding and investment profile for Rama Lakshmi Gorti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rama Lakshmi Gorti

Rama Lakshmi Gorti was first appointed on 27 Nov 2018 as Director at Medivast Pharmatech Private Limited. The most recent appointment on record is 23 Oct 2020 at Immunus Biotech Llp.

Rama Lakshmi Gorti held 2 earlier board appointments: Immunus Biotech Llp (Designated Partner, 23 Oct 2020 to 10 Sep 2024); Medivast Pharmatech Private Limited (Director, 27 Nov 2018 to 06 Mar 2021).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available